Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Udy

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2026
Vancomycin-resistant Enterococcus infective endocarditis: a case series and review of the literatureKelly A Cairns, Iain J Abbott, Andrew A Udy, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 31, 2019
Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis planTomoko Fujii, Andrew A Udy, Adam M Deane, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2015
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patientsJason A Roberts, Andrew A Udy, Paul Jarrett, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Critical Care (London, England)|January 31, 2015
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?Andrew A Udy, Jeffrey Lipman, Paul Jarrett, et al.
Journal of Neurotrauma|June 16, 2016
Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine ClearanceAndrew A Udy, Paul Jarrett, Melissa Lassig-Smith, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|July 12, 2022
Diabetes mellitus, glycaemic control, and severe COVID-19 in the Australian critical care setting: A nested cohort studyMark P Plummer, Louise Rait, Mark E Finnis, et al.
Intensive Care Medicine|November 9, 2021
Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysisTomoko Fujii, Georgia Salanti, Alessandro Belletti, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2026
Vancomycin-resistant Enterococcus infective endocarditis: a case series and review of the literatureKelly A Cairns, Iain J Abbott, Andrew A Udy, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 31, 2019
Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis planTomoko Fujii, Andrew A Udy, Adam M Deane, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2015
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patientsJason A Roberts, Andrew A Udy, Paul Jarrett, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Critical Care (London, England)|January 31, 2015
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?Andrew A Udy, Jeffrey Lipman, Paul Jarrett, et al.
Journal of Neurotrauma|June 16, 2016
Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine ClearanceAndrew A Udy, Paul Jarrett, Melissa Lassig-Smith, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|July 12, 2022
Diabetes mellitus, glycaemic control, and severe COVID-19 in the Australian critical care setting: A nested cohort studyMark P Plummer, Louise Rait, Mark E Finnis, et al.
Intensive Care Medicine|November 9, 2021
Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysisTomoko Fujii, Georgia Salanti, Alessandro Belletti, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Pageof 16